For example, breast cancer cell lines harboring DNM1L amplifications exhibited hypersensitivity to the ER stress-inducing drug thapsigargin and the XIAP inhibitor embelin as well as resistance to chemically distinct inhibitors of the phosphoinositide 3-kinase (PI3K) pathway (Fig. 1c, d). The gene discussed is PIK3CA; the disease is breast carcinoma.